SciELO - Scientific Electronic Library Online

 
vol.46 issue2Cost of precision medicine at a referral center for cystic fibrosisBacteriological diagnosis of tuberculosis in prison inmates: actions taken by the primary health care teams in prisons author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Jornal Brasileiro de Pneumologia

Print version ISSN 1806-3713On-line version ISSN 1806-3756

J. bras. pneumol. vol.46 no.2 São Paulo  2020  Epub Mar 02, 2020

https://doi.org/10.36416/1806-3756/e20190201 

LETTER TO THE EDITOR

Analysis of the incidence of latent Mycobacterium tuberculosis infection among primary health care professionals in two Brazilian capitals

Otávio Caliari Lima1  2 
http://orcid.org/0000-0002-7756-3739

Fernanda Mattos de Souza2  3 
http://orcid.org/0000-0003-2093-8816

Thiago Nascimento do Prado1  2 
http://orcid.org/0000-0001-8132-6288

Romildo Luiz Monteiro Andrade4 
http://orcid.org/0000-0001-6241-475X

Ethel Leonor Noia Maciel1  2 
http://orcid.org/0000-0003-4826-3355

1. Programa de Pós-Graduação em Saúde Coletiva, Universidade Federal do Espírito Santo, Vitória (ES) Brasil.

2. Laboratório de Epidemiologia - LABEPI - Universidade Federal do Rio de Janeiro, Rio de Janeiro (RJ) Brasil.

3. Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro (RJ) Brasil.

4. Núcleo de Epidemiologia Hospitalar, Hospital Universitário Cassiano Antonio Moraes, Universidade Federal do Espírito Santo, Vitória (ES) Brasil.


TO THE EDITOR:

One quarter of the world’s population is estimated to have latent Mycobacterium tuberculosis infection (LTBI), which generates potential new cases of active tuberculosis.1 Most cases progressing to active disease occur within the first 2-5 years after exposure to a tuberculosis index case.2 Health care professionals in whom there has been conversion of an LTBI test-tuberculin skin test (TST) or interferon-gamma release assay (IGRA)-are at risk of developing active disease. Therefore, the Brazilian National Ministry of Health3 recommends annual LTBI screening of this group and the prescription of prophylaxis for those cases in which any of the tests used in order to diagnose this infection have converted.

In the present study, QuantiFERON-TB Gold In-Tube test (QFT; Qiagen, Hilden, Germany), an IGRA, was used to determine the incidence of LTBI among primary health care professionals in two Brazilian capitals: Vitória (incidence rate = 40/100,000 population); and Manaus (incidence rate = 71/100,000 population).

This was a prospective cohort study, conducted between 2011 and 2013, involving primary health care professionals (physicians, nurses, nursing assistants or technicians, and community health agents) who received QFT at two different time points, between 18 and 24 months of follow-up.

All participating professionals gave written informed consent. Blood sample collection for the QFT and rapid HIV testing was carried out as described by Souza et al.,4 as were other methodological details.

In 2013, the cohort was evaluated again. In addition to the previous inclusion criteria, having a negative result on the first QFT was considered an inclusion criterion for the second phase of the study. To minimize variability, similar protocols were used for the baseline and follow-up tests.

Since, at that time, QFT results were not standardized for diagnosing LTBI in Brazil,5 participants with positive results in the first phase of the study were evaluated by an infectious disease specialist, who considered QFT and TST results. At that time, those with TST conversion were referred to the local tuberculosis control program.

The present study was approved by the Research Ethics Committee of the Federal University of Espírito Santo, located in the city of Vitória, Brazil (Protocol no. 007/10, March of 2010). All information was coded and stored anonymously in a database created with Microsoft Excel for Windows. For the descriptive analysis, we used STATA software, version 13.1 (StataCorp LP, College Station, TX, USA), and we included the estimate of the risk of QFT conversion, calculated using the actuarial method Cumulative Incidence Based on the Life-Table Interval Approach (Actuarial Life Table).6,7 In this method, the cumulative probability of an event over a given time interval (t0 − t) is the proportion of new events over that period, the denominator being the initial population (N0) corrected for losses (W) that are assumed to be evenly distributed over the time interval of interest; therefore, on average, it is as if all losses occur in the middle of the observation period (W/2), according to the following equation6,7:

R(t0t)=1(N0(W2))

where t0t is the time interval of interest (between 18 and 24 months); I is the number of new cases at t0t (QFT conversion occurred in 12 primary health care professionals); N0 is the number of individuals at risk at the beginning of the follow-up period (339 primary health care professionals); and W is the number of losses at t0t (276 primary health care professionals).

In the first phase of the study, 339 primary health care professionals were evaluated, 303 (89.4%) of whom were women, and the median age (interquartile range) was 41 (26-63) years.

The prevalence of LTBI, as determined by QFT, was 23.3% in the first phase of the study. Therefore, 260 primary health care professionals were eligible for follow-up, given that their first QFT result was negative. Because of the high turnover of these professionals in the public health care system, plus their absence from the health care facilities on the scheduled day, 63 primary health care professionals (24.2%) were available for the second evaluation.

The median age in the second phase of the study was 46 (39-53) years, 10 individuals (16.4%) reported morbidity, and only 7 (11.1%) reported having had close contact with someone with tuberculosis in the last 2 years. With regard to occupational and biosafety characteristics, 44 individuals (69.8%) reported having cared for tuberculosis patients in the last 2 years, and 40 (64.4%) reported that N95 masks were not always available for use.

Considering random losses and the ratio of the proposed calculation, the probability of QFT conversion between 18 and 24 months of follow-up was 7.4%.

Studies have shown that the rate of IGRA conversion among health care professionals in low- and middle-income countries ranges from 10-30%.8 In studies conducted in primary and secondary care settings in countries with high tuberculosis incidence rates, the reported rate of IGRA conversion ranges from 14-22%.9 In a study conducted in a tertiary care setting in India, the rate of IGRA conversion was 11.6%.10 However, in none of those studies were losses to follow-up considered in the calculation of the incidence of IGRA conversion.

To our knowledge, this was the first study to provide estimates of the incidence of LTBI among primary health care professionals in Brazil and to use an IGRA as a diagnostic test to evaluate this measure of frequency. However, the present study has some limitations: loss to follow-up was high (approximately 75%); and, because there was no reference test for the diagnosis of LTBI, the estimated incidence of LTBI may have been influenced by the performance of the QFT.

Among the tuberculosis control strategies proposed by the World Health Organization and the End TB strategy, the diagnosis and treatment of LTBI is of note as one of the actions that can produce the necessary changes. Finally, proper assessment, screening, and treatment of people at risk for LTBI, such as health care professionals, are some of the actions that can contribute to ending the tuberculosis epidemic by 2035.

REFERENCES

1 Behr MA, Edelstein PH, Ramakrishnan L. Revisiting the timetable of tuberculosis. BMJ. 2018;362:k2738. https://doi.org/10.1136/bmj.k2738Links ]

2 World Health Organization [homepage on the Internet]. Geneva: World Health Organization [updated 2018; cited 2019 Mar 10]. Latent tuberculosis infection: Updated and consolidated guidelines for programmatic management. [internet]. 2018. Available from: https://www.who.int/tb/publications/2018/latent-tuberculosis-infection/en/ [ Links ]

3 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Protocolo de vigilância da infecção latente pelo Mycobacterium tuberculosis no Brasil. Brasília: Ministério da Saúde; 2018. [ Links ]

4 de Souza FM, do Prado TN, Pinheiro Jdos S, Peres RL, Lacerda TC, Loureiro RB, et al. Comparison of interferon-? release assay to two cut-off points of tuberculin skin test to detect latent Mycobacterium tuberculosis infection in primary health care workers. PLoS One. 2014;9(8):e102773. https://doi.org/10.1371/journal.pone.0102773Links ]

5 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Manual de recomendações para o controle da tuberculose no Brasil. Brasília: Ministério da Saúde; 2011. [ Links ]

6 Jekel JF, Katz DL, Elmore JG, Wild D. Epidemiology, biostatistics, and preventive medicine. Philadelphia: Elsevier Health Sciences; 2007. [ Links ]

7 Szklo M, Nieto FJ. Epidemiology: Beyond the Basics. 4th ed. Burlington (MA): Jones & Bartlett Learning; 2018. [ Links ]

8 Apriani L, McAllister S, Sharples K, Alisjahbana B, Ruslami R, Hill PC, et al. Latent tuberculosis infection in health care workers in low- and middle-income countries: an updated systematic review. Eur Respir J. 2019;53(4). pii: 1801789. https://doi.org/10.1183/13993003.01789-2018Links ]

9 Machado PC, Valim ARM, Maciel ELN, Prado TN, Borges TS, Daronco A, et al. Comparison of tuberculin test and interferon-gamma release assay for diagnosing latent tuberculosis in Community Health Workers, State of Rio Grande do Sul, Brazil, 2012 [Article in Portuguese]. Epidemiol Serv Saude. 2014;23(4):675-681. https://doi.org/10.5123/S1679-49742014000400009Links ]

10 Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med. 2006;174(3):349-55. https://doi.org/10.1164/rccm.200604-472OCLinks ]

FINANCIAL SUPPORT The present study received financial support from the Brazilian Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq, National Council for Scientific and Technological Development; Universal Mandate no. 14/2009) and the Fundação de Amparo à Pesquisa do Espírito Santo (FAPES, Foundation for the Support of Research in the State of Espírito Santo; Universal Mandate no. 012/11).

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License